Selected data models

You must log in to select data models for download or further analysis.

3 Search results.
Relevance Rating New first Old first

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Best overall response assessment; New tumor biopsy/ sample (Report Final and Annex Report 2 Final)

- 10/30/20 - 1 form, 3 itemgroups, 29 items, 1 language
Itemgroups: Administrative, Best overall response assessment, New tumor biopsy/ sample
Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

AMC-070 Overall Assessment Form (RK6)

- 10/9/17 - 1 form, 4 itemgroups, 13 items, 1 language
Itemgroups: Header - Overall Assessment Form, Overall Assessment, Disease Response, Comments
AMC-070 Overall Assessment Form (RK6) Lenalidomide in Treating Patients With AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E4BBD6-693F-9CA4-E040-BB89AD437D79

CCR 2011 Template - Course Assessment

- 7/15/17 - 1 form, 1 itemgroup, 9 items, 1 language
Itemgroup: Course Assessment
The course assessment information when the course is completed, and the patient is evaluated or taken off treatment. Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ACEDB2DF-2AE4-2B69-E040-BB89AD437A84

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial